BioPharma Resources

Free tool

Company pipelines

Each company page lists its approved NDAs and BLAs, its expedited approvals, and its registered drug trials by phase, a public view of its pipeline. Large companies are merged across the names they file under; for everyone else the Drugs@FDA sponsor name is used as written.

Last checked: Nov 18, 2026Source: Drugs@FDA, ClinicalTrials.gov

Large drug developers

Ranked by novel approvals in Drugs@FDA, including acquired companies' drugs.

CompanyNovel approvalsNDAs and BLAsStill marketed
PfizerPFE130423168
NovartisNVS86224116
AbbVieABBV6219883
SanofiSNY6211343
Merck & Co.MRK5914547
Johnson & Johnson (Janssen)JNJ5113160
Roche (Genentech)RHHBY519549
GSKGSK4914857
Eli LillyLLY449140
Bristol Myers SquibbBMY417537
AstraZenecaAZN398447
TakedaTAK336340
BayerBAYRY329951
Gilead SciencesGILD213833
Boehringer Ingelheim215428
AmgenAMGN204031
TevaTEVA187730
AstellasALPMY152715
UCB113018
BiogenBIIB101212
Otsuka96455
Eisai91511
RegeneronREGN899
Vertex PharmaceuticalsVRTX7109
BioMarinBMRN788
Novo NordiskNVO62016
Daiichi SankyoDSNKY676
Jazz PharmaceuticalsJAZZ6119
IncyteINCY566
Alnylam PharmaceuticalsALNY444
BeOne Medicines (BeiGene)ONC365
Ionis PharmaceuticalsIONS333
Neurocrine BiosciencesNBIX244
argenxARGX122
ModernaMRNA000

Other sponsors

By novel approvals, as named in Drugs@FDA.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.